BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 23680655)

  • 1. Neurodegenerative disorder FTDP-17-related tau intron 10 +16C → T mutation increases tau exon 10 splicing and causes tauopathy in transgenic mice.
    Umeda T; Yamashita T; Kimura T; Ohnishi K; Takuma H; Ozeki T; Takashima A; Tomiyama T; Mori H
    Am J Pathol; 2013 Jul; 183(1):211-25. PubMed ID: 23680655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy.
    Hogg M; Grujic ZM; Baker M; Demirci S; Guillozet AL; Sweet AP; Herzog LL; Weintraub S; Mesulam MM; LaPointe NE; Gamblin TC; Berry RW; Binder LI; de Silva R; Lees A; Espinoza M; Davies P; Grover A; Sahara N; Ishizawa T; Dickson D; Yen SH; Hutton M; Bigio EH
    Acta Neuropathol; 2003 Oct; 106(4):323-36. PubMed ID: 12883828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tau N279K exon 10 splicing mutation recapitulates frontotemporal dementia and parkinsonism linked to chromosome 17 tauopathy in a mouse model.
    Dawson HN; Cantillana V; Chen L; Vitek MP
    J Neurosci; 2007 Aug; 27(34):9155-68. PubMed ID: 17715352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies.
    Gu J; Chen F; Iqbal K; Gong CX; Wang X; Liu F
    J Biol Chem; 2017 Jun; 292(25):10600-10612. PubMed ID: 28487370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperexcitability and epileptic seizures in a model of frontotemporal dementia.
    García-Cabrero AM; Guerrero-López R; Giráldez BG; Llorens-Martín M; Avila J; Serratosa JM; Sánchez MP
    Neurobiol Dis; 2013 Oct; 58():200-8. PubMed ID: 23774255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of alternative splicing of tau exon 10.
    Qian W; Liu F
    Neurosci Bull; 2014 Apr; 30(2):367-77. PubMed ID: 24627328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies.
    Luk C; Compta Y; Magdalinou N; Martí MJ; Hondhamuni G; Zetterberg H; Blennow K; Constantinescu R; Pijnenburg Y; Mollenhauer B; Trenkwalder C; Van Swieten J; Chiu WZ; Borroni B; Cámara A; Cheshire P; Williams DR; Lees AJ; de Silva R
    J Neurochem; 2012 Nov; 123(3):396-405. PubMed ID: 22862741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A minimal length between tau exon 10 and 11 is required for correct splicing of exon 10.
    Yu Q; Guo J; Zhou J
    J Neurochem; 2004 Jul; 90(1):164-72. PubMed ID: 15198676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An SRp75/hnRNPG complex interacting with hnRNPE2 regulates the 5' splice site of tau exon 10, whose misregulation causes frontotemporal dementia.
    Wang Y; Wang J; Gao L; Stamm S; Andreadis A
    Gene; 2011 Oct; 485(2):130-8. PubMed ID: 21723381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frontotemporal dementia with novel tau pathology and a Glu342Val tau mutation.
    Lippa CF; Zhukareva V; Kawarai T; Uryu K; Shafiq M; Nee LE; Grafman J; Liang Y; St George-Hyslop PH; Trojanowski JQ; Lee VM
    Ann Neurol; 2000 Dec; 48(6):850-8. PubMed ID: 11117541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dynamic neuropathology of tauopathy].
    Murayama S
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1101-3. PubMed ID: 12235808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy.
    Zhang B; Higuchi M; Yoshiyama Y; Ishihara T; Forman MS; Martinez D; Joyce S; Trojanowski JQ; Lee VM
    J Neurosci; 2004 May; 24(19):4657-67. PubMed ID: 15140937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DeltaK280 mutation in MAP tau favors exon 10 skipping in vivo.
    van Swieten JC; Bronner IF; Azmani A; Severijnen LA; Kamphorst W; Ravid R; Rizzu P; Willemsen R; Heutink P
    J Neuropathol Exp Neurol; 2007 Jan; 66(1):17-25. PubMed ID: 17204933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous nuclear ribonucleoprotein E3 modestly activates splicing of tau exon 10 via its proximal downstream intron, a hotspot for frontotemporal dementia mutations.
    Wang Y; Gao L; Tse SW; Andreadis A
    Gene; 2010 Feb; 451(1-2):23-31. PubMed ID: 19914360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation at position +11 in the intron following exon 10 of the tau gene in FTDP-17.
    Kowalska A; Hasegawa M; Miyamoto K; Akiguchi I; Ikemoto A; Takahashi K; Araki W; Tabira T
    J Appl Genet; 2002; 43(4):535-43. PubMed ID: 12441638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
    Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
    Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy.
    Smith PY; Delay C; Girard J; Papon MA; Planel E; Sergeant N; Buée L; Hébert SS
    Hum Mol Genet; 2011 Oct; 20(20):4016-24. PubMed ID: 21807765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-β peptide alteration of tau exon-10 splicing via the GSK3β-SC35 pathway.
    Chen KL; Yuan RY; Hu CJ; Hsu CY
    Neurobiol Dis; 2010 Nov; 40(2):378-85. PubMed ID: 20615469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the cholinergic pathology in the P301L tau transgenic pR5 model of tauopathy.
    Köhler C; Bista P; Götz J; Schröder H
    Brain Res; 2010 Aug; 1347():111-24. PubMed ID: 20513372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of dopaminoreceptive neuron causes L-dopa resistant parkinsonism in tauopathy.
    Chiba S; Takada E; Tadokoro M; Taniguchi T; Kadoyama K; Takenokuchi M; Kato S; Suzuki N
    Neurobiol Aging; 2012 Oct; 33(10):2491-505. PubMed ID: 22169201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.